Finance

Lists
4888:TYO
Stella Pharma Corp
Â¥452.00
-0.88%
(-4.00) 1D
Oct 7, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4888...
Open
Â¥456
High
Â¥469
Low
Â¥442
Mkt. cap
16.60B
Avg. vol.
363.42K
Volume
664.50K
52-wk high
Â¥995
52-wk low
Â¥200
EPS
-Â¥25
No. of employees
47
Open
Â¥456
High
Â¥469
Low
Â¥442
Mkt. cap
16.60B
Avg. vol.
363.42K
Volume
664.50K
52-wk high
Â¥995
52-wk low
Â¥200
EPS
-Â¥25
No. of employees
47
News stories
From web sources and news partners
About Stella Pharma Corp
CEOTomoyuki Asano
Employees47
FoundedJun 1, 2007
Headquarters-
SectorPharmaceutical industry
Websitestella-pharma.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
108.00M
61.00M
62.00M
92.00M
Cost of goods sold
22.00M
1.00M
8.00M
13.00M
Cost of revenue
22.00M
1.00M
8.00M
13.00M
Research and development expenses
-
-
301.00M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
233.00M
274.00M
-25.00M
324.00M
Operating expense
233.00M
274.00M
290.00M
324.00M
Total operating expenses
255.00M
275.00M
298.00M
337.00M
Operating income
-147.00M
-214.00M
-236.00M
-245.00M
Other non operating income
-2.00M
12.00M
-29.00M
20.00M
EBT including unusual items
-150.00M
-204.00M
-268.00M
-228.00M
EBT excluding unusual items
-150.00M
-204.00M
-268.00M
-228.00M
Income tax expense
1.00M
1.00M
-
-
Effective tax rate
-0.67%
-0.49%
-
-
Other operating expenses
-
-
-
-
Net income
-151.00M
-205.00M
-268.00M
-228.00M
Net profit margin
-139.81%
-336.07%
-432.26%
-247.83%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.00M
-2.00M
-3.00M
-3.00M
Net interest expenses
-1.00M
-2.00M
-3.00M
-3.00M
Depreciation and amortization charges
-
-
14.00M
-
EBITDA
-140.00M
-205.50M
-229.00M
-238.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps